Pfizer’s March quarter revenue went up by 8% from last year, while its Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) went up by 20% year-on-year and 56% from the December quarter.
The company’s EBITDA margin expanded by 11 percentage points to 38.4% from 27.1% last year.
The board of Pfizer also approved a final dividend of ₹35 per share and a special dividend of ₹100 per share, on the occasion of the company completing 75 years of India operations.
Additionally, the board also announced a special dividend of ₹30 per share due to the gain it had on the transfer of assignment of a leasehold land and building constructed on that land.
This takes the total dividend payout for shareholders to ₹165 per share. Pfizer has fixed July 9, 2025 as the record date for the dividend payout.
The last instance of the company announcing such a large dividend payout for its shareholders was back in May 2020, when the company had announced a special dividend of ₹320 per share.
Shares of Pfizer are trading 11% higher on Tuesday at ₹4,961.5. The stock is up 18% in the last one month.
